Share

GLYVAR

GLYcemic Variability assessed by continuous glucose monitoring and Antiplatelet Responsiveness in patients undergoing coronary stenting (GLYVAR study)

Project Objectives

The aim of our study is to evaluate the correlation between periprocedural glycemic variability (measured by a subcutaneous continuous glucose monitoring system, iPro™) and platelet reactivity (assessed by VerifyNow System and measured in terms of Platelet Reactivity Units) in diabetic patients undergoing percutaneous coronary intervention.

Type of study: pilot, observational, prospective study.

Primary Endpoints: 

  • Correlation between periprocedural glycemic variability and platelet reactivity (PRU) in the study population
  • Correlation between periprocedural glycemic variability and incidence of Net Adverse Clinical Events (NACE) (death, myocardial infarction, need for revascularization – PCI or CABG, stroke, major and minor bleeding)

Start and End Dates

Not yet started; waiting for Ethical Committee approval 

Principal Investigator

  • Dr. Annunziata Nusca, Principal Investigator
  • Prof. Germano Di Sciascio

Host Institution

Campus Bio-Medico University of Rome

magnifiercrossmenuchevron-downchevron-leftchevron-right